$181.7M in SYK Stock Sold in Two Days by Ronda Stryker After Earnings Guidance

Ronda E. Stryker disclosed a heavy two-day sell window in SYK: roughly $181.7M sold across February 4-5, 2026 (about 500,000 shares total).

Transaction Breakdown

Date	Action	Shares	Estimated Value
2026-02-04	S in SYK	250,000	~$90.73M
2026-02-05	S in SYK	250,000	~$90.99M

The size is large, but the pattern is staged execution over adjacent sessions, which often points to programmatic liquidity management instead of a one-shot panic exit.

External Context: Post-Earnings Setup

Stryker's investor release for fourth-quarter and full-year 2025 results emphasized continued sales growth and 2026 planning. MedTech coverage also focused on procedure and segment momentum rather than a demand collapse backdrop.

Sources: Stryker investor release, MedTech Dive.

Institutional Holder Backdrop

SYK remains widely held by large institutions including Vanguard, BlackRock, State Street, JPMorgan, Banque Transatlantique SA, and Rehmann Capital Advisory Group.

Key Facts

Insider	Ronda E. Stryker
Ticker	SYK
Sell window	2026-02-04 to 2026-02-05
Total sold shares (window)	500,000
Total estimated value	~$181.7M

What to Watch

• SYK follow-through after the filing window: relative price resilience would support a liquidity-event interpretation.
• Insider cadence: repeated block windows in coming months would be more meaningful than one two-day sequence.
• 13F positioning from Vanguard, BlackRock, and State Street: large reductions would confirm broader institutional de-risking.